Company overview
Codexis specializes in enzyme engineering and biocatalysis solutions for pharmaceutical manufacturing, including custom enzymes for small molecule APIs via CodeEvolver® technology. Their ECO Synthesis™ platform enables scalable, sustainable production of RNAi therapeutics like siRNA through enzymatic synthesis, reducing waste and improving efficiency over chemical methods. With over 22 years of expertise, they support greener manufacturing for next-generation oligonucleotide therapies.
Codexis is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include codexis, enzyme engineering, rna manufacturing, eco synthesis, sirna therapeutics, biocatalysis.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Codexis include Synthesis — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.codexis.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- codexis, enzyme engineering, rna manufacturing, eco synthesis, sirna therapeutics, biocatalysis
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are Codexis' key capabilities in pharma manufacturing?
- Codexis offers enzyme engineering with CodeEvolver® AI-driven technology for custom enzymes in small molecule APIs and ECO Synthesis™ for scalable RNAi/siRNA production, improving yield, quality, and sustainability.
- How does ECO Synthesis™ address RNA manufacturing challenges?
- ECO Synthesis™ uses engineered enzymes for high-fidelity RNA synthesis and ligation, enabling gram-scale production with minimal waste, higher efficiency, and scalability for therapeutics.
- What industries or geographies does Codexis serve?
- Codexis provides biocatalysis and RNA manufacturing solutions to pharmaceutical companies globally, focusing on RNAi therapeutics, small molecule APIs, and sustainable bioprocessing.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
